Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 11/20 | 0.52 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | ADH1B | P00325 | 1/20 | 0.41 |
| ▸ | ADH1C | P00326 | 1/20 | 0.41 |
| ▸ | ADH1A | P07327 | 1/20 | 0.41 |
| ▸ | ADH4 | P08319 | 1/20 | 0.41 |
| ▸ | ADH7 | P40394 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | PPARA | Q07869 | 2/20 | 0.37 |
| ▸ | GBA1 | P04062 | 1/20 | 0.35 |
| ▸ | CASP2 | P42575 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3373268 | 1.00 | EPHX1 (0.52) | EPHX1TSHRALDH1A1ADH1BADH1C | |
| SCHEMBL37597 | 1.00 | EPHX1 (0.52) | EPHX1TSHRALDH1A1ADH1BADH1C | |
| SCHEMBL10589508 | 1.00 | EPHX1 (0.52) | EPHX1TSHRALDH1A1ADH1BADH1C | |
| SCHEMBL7110706 | 1.00 | EPHX1 (0.52) | EPHX1TSHRALDH1A1ADH1BADH1C | |
| SCHEMBL3369909 | 1.00 | EPHX1 (0.52) | EPHX1TSHRALDH1A1ADH1BADH1C | |
| Hydrochloric Acid SCHEMBL8041489 | 0.98 | EPHX1 (0.50) | EPHX1TSHRALDH1A1ADH1BADH1C | |
| Bromide SCHEMBL1459266 | 0.98 | EPHX1 (0.50) | EPHX1TSHRALDH1A1ADH1BADH1C | |
| Hydrochloric Acid SCHEMBL28937648 | 0.98 | EPHX1 (0.50) | EPHX1TSHRALDH1A1ADH1BADH1C | |
| SCHEMBL3370320 | 0.97 | EPHX1 (0.48) | EPHX1TSHRALDH1A1ADH1BADH1C | |
| SCHEMBL3369009 | 0.90 | EPHX1 (0.41) | EPHX1TSHRALDH1A1ADH1BADH1C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9809717-B2 | Antimicrobial-coated medical articles | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2017-11-07 | — | — | US | disclosed |
| EP-2576471-B1 | ANTIMICROBIAL COATED MEDICAL ARTICLES | 3M INNOVATIVE PROPERTIES CO (US) | 2017-10-25 | — | — | EP | disclosed |
| EP-2576472-B1 | ANTIMICROBIAL COATINGS | 3M INNOVATIVE PROPERTIES CO (US) | 2016-03-23 | — | — | EP | disclosed |
| US-20150175812-A1 | ANTIMICROBIAL COATINGS | 3M INNOVATIVE PROPERTIES CO (US) | 2015-06-25 | — | — | US | disclosed |
| US-20150024019-A1 | ANTIMICROBIAL-COATED MEDICAL ARTICLES | 3M INNOVATIVE PROPERTIES COMPANY | 2015-01-22 | — | — | US | disclosed |
| EP-2576472-A2 | ANTIMICROBIAL COATINGS | 3M Innovative Properties Company (US) | 2013-04-10 | — | — | EP | disclosed |
| EP-2576471-A2 | ANTIMICROBIAL COATED MEDICAL ARTICLES | 3M Innovative Properties Company (US) | 2013-04-10 | — | — | EP | disclosed |
| US-20120015002-A1 | ANTIMICROBIAL COATINGS | 3M INNOVATIVE PROPERTIES COMPANY | 2012-01-19 | — | — | US | disclosed |
| WO-2011150103-A2 | ANTIMICROBIAL–COATED MEDICAL ARTICLES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2011-12-01 | — | — | WO | disclosed |
| WO-2011150001-A2 | ANTIMICROBIAL COATINGS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2011-12-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120015002-A1 | ANTIMICROBIAL COATINGS | ARG1, CAPG, CLSPN | EPHX1 3972/4885TSHR 4723/4885ALDH1A1 1890/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.